The Clinical Benefit Of Mepolizumab Treatment Is Independent Of Baseline Maintenance Oral Corticosteroid Use: Results From The Real-World REALITI-A Study

被引:0
|
作者
Liu, Mark [1 ]
Schleich, Florence [2 ]
Lee, Jason [3 ]
Pelaia, Girolamo [4 ]
Sanchez, Carlos Almonacid [5 ]
Heaney, Liam [6 ]
Alfonso-Cristancho, Rafael [7 ]
Jakes, Rupert [8 ]
Price, Robert [9 ]
Maxwell, Aoife [10 ]
Howarth, Peter [11 ]
机构
[1] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA
[2] Ctr Hosp Univ Sart Tilman Liege, Liege, Belgium
[3] Toronto Allergy & Asthma Clin, Toronto, ON, Canada
[4] Magna Graecia Univ Catanzaro, Catanzaro, Italy
[5] Hosp Ramon & Cajal, Madrid, Spain
[6] Queens Univ Belfast, Belfast, Antrim, North Ireland
[7] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[8] GSK, Epidemiol, London, England
[9] GSK, Biostat, Stevenage, Herts, England
[10] GSK, Value Evidence & Outcomes, Global Med, Stevenage, Herts, England
[11] GSK House, Global Specialty & Primary Care TA, Brentford, Middx, England
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
443
引用
收藏
页码:AB147 / AB147
页数:1
相关论文
共 50 条
  • [1] REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma
    Pilette, Charles
    Canonica, Giorgio Walter
    Chaudhuri, Rekha
    Chupp, Geoffrey
    Lee, F. Eun-Hyung
    Lee, Jason Kihyuk
    Almonacid, Carlos
    Welte, Tobias
    Alfonso-Cristancho, Rafael
    Jakes, Rupert W.
    Maxwell, Aoife
    Price, Robert G.
    Howarth, Peter
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (10): : 2646 - 2656
  • [2] Effectiveness and safety of mepolizumab in real-world clinical practice: The REALITI-A study
    Harrison, T.
    Canonica, G.
    Gemzoe, K.
    Maxwell, A.
    Yang, S.
    Joksaite, S.
    O'Reilly, R.
    Van Dyke, M.
    Albers, F. C.
    Kwon, N.
    [J]. PNEUMOLOGIE, 2020, 74 : S25 - S25
  • [3] National Differences in Real-World Outcomes with Mepolizumab Treatment for Patients with Severe Asthma: Results from the REALITI-A Study
    Lee, J. K.
    Schleich, F.
    Canonica, G. W.
    Munoz, X.
    Chaudhuri, R.
    Lee, F. E.
    Howarth, P.
    Price, R. G.
    Yang, S.
    Jakes, R. W.
    Maxwell, A.
    Cristancho, R. Alfonso
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [4] Real-World Impact of Mepolizumab on the Oral Corticosteroid Freedom Component of Clinical Remission in Severe Eosinophilic Asthma: International, Prospective REALITI-A Study
    Chupp, Geoffrey
    Heaney, Liam
    Price, Rob
    Brusselle, Guy
    Gardiner, Frances
    Raimondi, Alejandro
    Chaudhuri, Rekha
    Howarth, Peter
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB20 - AB20
  • [5] Characteristics of patients receiving mepolizumab in real-world practice - REALITI-A study
    Kwon, Namhee
    Gemzoe, Kim
    Worsley, Sally
    Gunsoy, Necdet
    Joksaite, Sandra
    Van Dyke, Melissa
    Bettinson, Carys
    Albers, Frank
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [6] Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study
    Harrison, Tim
    Canonica, G. Walter
    Gemzoe, Kim
    Maxwell, Aoife
    Yang, Shibing
    Joksaite, Sandra
    O'Reilly, Ronan
    Van Dyke, Melissa
    Albers, Frank C.
    Kwon, Namhee
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [7] EFFECTIVENESS AND SAFETY OF MEPOLIZUMAB IN REAL-WORLD CLINICAL PRACTICE: UK PATIENT OUTCOMES FROM THE REALITI-A STUDY
    Kerr, W. A. F.
    Harrison, T. W.
    Loveday, K.
    Joksaite, S.
    Kwon, N.
    [J]. THORAX, 2019, 74 : A140 - A140
  • [8] The Impact of Comorbidities and Clinical Characteristics on Real-World Mepolizumab Effectiveness in Patients with Severe Asthma: Results from the REALITI-A Study
    Chupp, G. L.
    Heaney, L. G.
    Pelaia, G.
    Welte, T.
    Sanchez, C. Almonacid
    Lee, J. K.
    Maxwell, A.
    Price, R. G.
    Jakes, R. W.
    Cristancho, R. Alfonso
    Howarth, P.
    Brusselle, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [9] Mepolizumab Provides Real-World Clinical Benefits in Severe Eosinophilic Asthma Irrespective of Baseline Lung Function: Results From the REALITI-A Study at 2 Years
    Bagnasco, D.
    Pilette, C.
    Lougheed, M.
    Caruso, C.
    Echave-Sustaeta, J.
    Dennison, P.
    Verghis, R.
    Jakes, R.
    Rais, M.
    Howarth, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [10] Mepolizumab improves lung function under real-world settings in REALITI-A study
    Schleich, Florence
    Chaudhuri, Rekha
    Canonica, Giorgio Walter
    Munoz Gall, Xavier
    Funke, Faustina
    Pek, Bonavuth
    Pollard, Stephen
    Maxwell, Aoife
    Joksaite, Sandra
    Price, Robert G.
    O'Reilly, Ronan
    Van Dyke, Melissa K.
    Yang, Shibing
    Howarth, Peter
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56